frequent use of triptans (Imitrex, etc) can actually EXACERBATE migraines

February 2002

There's increasing evidence that frequent use of triptans (Imitrex, etc) can actually EXACERBATE migraines.

This is similar to the rebound or withdrawal headaches that patients get from overusing analgesics.

Overuse of triptans can increase migraine frequency to the point where patients end up with chronic daily headaches.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

ibuprofen might reduce the benefit of taking low-dose aspirin
Cardiology More patients will be taking aspirin for primary prevention of coronary heart disease (CHD)
Cardiology whether to treat patients with "white-coat hypertension"
Migraine frequent use of triptans (Imitrex, etc) can actually EXACERBATE migraines
whether vitamin A causes hip fractures
ginkgo can cause seizures
Women's Health women ask if they can insert their birth control pill VAGINALLY
Women's Health whether antibiotics reduce the efficacy of oral contraceptives
Hematology & Oncology Arimidex (anastrozole) is more effective than tamoxifen for treating EARLY breast cancer
Dyslipidemia Advicor, the first combo drug for dyslipidemia
Infectious Diseases single-dose or three-day regimens of Zithromax (azithromycin) for acute otitis media in children
Dermatology new OTC Lotrimin that DOESN'T contain clotrimazole
Dermatology Solaraze, a new topical gel for actinic keratoses
Now that Claritin is going off patent, Schering is coming out with Clarinex
Practice chart of new drugs approved by the FDA in 2001
Hematology & Oncology triptorelin, Trelstar LA, for the palliative treatment of advanced prostate cancer